2 hrs ago | US Food and Drug Administration
Sandoz US Announces Voluntary Nationwide Recall of two lots of...
May 20, 2013 - Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer.
'Leapstars' getting off that couch
Arriving at Melton Estate for the 2013 RISE women in business forum in Christchurch last week, one can hear from the carpark the sound of laughter and clapping.
Arthritis Drug Simponi (Golimumab) Gets Expanded Indication for Ulcerative Colitis
The FDA has approved a new use for Simponi injection to treat adults with moderate-to-severe ulcerative colitis.
Daily Checkup: Advances in arthritis research
' height='423' itemprop='associatedMedia' alt='' width='635' src='http://assets.nydailynews.com/polopoly_fs/1.1343711.1368556801!/img/httpImage/image.jpg_gen/derivatives/landscape_635/checkup19f-1-web.jpg' /> THE SPECIALIST: The acting chief of rheumatology at Mount Sinai, Dr.
A plant-based diet: 9 fruits and vegetables to help battle arthritis pain
Suffers of rheumatoid arthritis may find some relief by incorporating more plant-based foods and less meat and dairy products.
Moving forward in rheumatoid arthritis
May 17th 2013 - Edison Investment Research today published a report on Neovacs entitled "Moving Forward In Rheumatoid Arthritis". In summary, the report says: Neovacs intends to initiate a Phase IIb trial with its lead product TNFI -Kinoid in rheumatoid arthritis .
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease Galapagos to fund and complete Phase 2 study; AbbVie to pay Galapagos $50 million upon successful completion, expected in 2015 Galapagos to fund and complete Phase 2 study; AbbVie to pay Galapagos $50 million upon successful completion, expected in 2015 /PRNewswire/ -- ... (more)
Antares: Reiteration Of My Buy Recommendation
It has been some time since I have written on Antares ; in fact, my last note was in September 2012.
Sanofi and Regeneron's Latest Partnership
This antibody is being tested in combination with methotrexate, a drug often used for the treatment of rheumatoid arthritis, and will be compared to Amgen Enbrel.
Endothelial Dysfunction in Rheumatoid Arthritis: The Role of Monocyte ...
From the Department of Cardiovascular Medicine , and the Department of Rheumatology , First Affiliated Hospital of Medical School, Cardiovascular Research Center , and Key Laboratory of Environment and Genes Related to Diseases , Medical School, Xi'an Jiaotong University, Xi'an, China; and Division of Biomedical Sciences, University of California, ... (more)
UPDATE 1-U.S. FDA approves J&J's Simponi to treat ulcerative colitis
The U.S. Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.
Rheumatoid Arthritis: Clinical Aspects [322-355]: 322. The Effect...
Rheumatoid Arthritis: Clinical Aspects [322-355]: 322. The Effect of Biologics on Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Systematic Literature Review Background: Patients with RA have an increased prevalence of cardiovascular disease .
May is National Arthritis Awareness Month
Arthritis is a complex family of musculoskeletal disorders consisting of more than 100 different diseases or conditions that destroy joints, bones, muscles, cartilage and other connective tissues, hampering or halting physical movement.
Using Tylenol in treatment for RA
Dear Dr. Roach: I am an 80-plus-year-old man with rheumatoid arthritis. My doctor has reduced my methotrexate dosage due to his concern about kidney damage.
TiGenix : business update & financial highlights for Q1 of 2013
Financial Highlights for Q1 of 2013 A ChondroCelect Sales up 55% over Q1 2012 A Cx611 Phase IIa delivers positive results in refractory RA A Cx601 Phase III enrollment on schedule Leuven - May 14, 2013 -TiGenix NV , the European leader in cell therapy, gives an update of its business activities and provides the financial highlights for the first ... (more)
The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) finishing down 27 points, or 0.2%, as investors seemed unsure of how to react to news that the Fed may end its stimulus program.
Galapagos to present three posters on GLPG0634 at EULAR
Mechelen, Belgium; 13 May 2013 - Galapagos NV announced today that the Company will present three posters on selective JAK1 inhibitor GLPG0634 at the EULAR Annual European Congress of Rheumatology, which will take place from 12-15 June 2013 in Madrid, Spain.
Huge drug cost disparities seen in health overhaul - Mon, 13 May 2013 PST
Cancer patients could face high costs for medications under President Barack Obama's health care law, industry analysts and advocates warn.
Fat Triggers Rheumatoid Arthritis: Discovery Paves Way For New Gene Therapies, Treatments
Main Category: Arthritis / Rheumatology Also Included In: Obesity / Weight Loss / Fitness ; Genetics Article Date: 13 May 2013 - 0:00 PDT Scientists have discovered that fat cells in the knee secrete a protein linked to arthritis , a finding that paves the way for new gene therapies that could offer relief and mobility to millions worldwide.
Collecting DVDs for sick children
Kayla and her brothers are sorting through dozens of DVD movies for kids. Kayla will be donating them to South Florida hospitals.